Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Trevena Inc

TRVN
Current price
1.97 USD +0.22 USD (+12.29%)
Last closed 1.72 USD
ISIN US89532E1091
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 449 986 USD
Yield for 12 month -86.27 %
1Y
3Y
5Y
10Y
15Y
TRVN
21.11.2021 - 28.11.2021

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. Address: 955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

100 USD

P/E ratio

Dividend Yield

Current Year

+3 125 000 USD

Last Year

-418 000 USD

Current Quarter

+325 000 USD

Last Quarter

+20 000 USD

Current Year

+1 455 000 USD

Last Year

-3 436 000 USD

Current Quarter

+133 000 USD

Last Quarter

-156 000 USD

Key Figures TRVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -35 009 000 USD
Operating Margin TTM -2000.92 %
PE Ratio
Return On Assets TTM -71.51 %
PEG Ratio
Return On Equity TTM -1014.58 %
Wall Street Target Price 100 USD
Revenue TTM 443 000 USD
Book Value -22.23 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -89.2 %
Dividend Yield
Gross Profit TTM -3 436 000 USD
Earnings per share -56.5 USD
Diluted Eps TTM -56.5 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TRVN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TRVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 13.08.2024
Dividend Date

Stock Valuation TRVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 48.7576
Price Sales TTM 3.2731
Enterprise Value EBITDA 0.2105
Price Book MRQ 0.3564

Financials TRVN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TRVN

For 52 weeks

1.13 USD 19.23 USD
50 Day MA 3.53 USD
Shares Short Prior Month 20 075
200 Day MA 8.41 USD
Short Ratio 1
Shares Short 59 358
Short Percent 7.03 %